DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2023; 148(01/02): 10DOI: 10.1055/a-1938-7306 Aktuell publiziert Kommentar zu „Diabetes Typ 2: Telemedizinische Intervention verbessert Outcome“ Recommend Article Abstract Buy Article(opens in new window) Comment on:Diabetes Typ 2: Telemedizinische Intervention verbessert OutcomeDtsch Med Wochenschr 2023; 148(01/02): 9-9DOI: 10.1055/a-1938-7273 Full Text References Literatur 1 Lean ME, Leslie WS, Barnes AC. et al Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 2018; 391: 541-551 . Epub 2017 Dec 5. PMID: 29221645. 2 Lean MEJ, Leslie WS, Barnes AC. et al Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 2019; 7 (05) 344-355 . Epub 2019 Mar 6. PMID: 30852132. 3 Kempf K, Altpeter B, Berger J. et al. Efficacy of the Telemedical Lifestyle intervention Program TeLiPro in Advanced Stages of Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2017; 40 (07) 863-871 4 https://innovationsfonds.g-ba.de/projekte/neue-versorgungsformen/telipro-telemedizinisches-lebensstil-interventions-programm-fuer-typ-2-diabetiker.178